Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what the timetable is for new genetic technology to be introduced to target prostate cancer treatment on the NHS.

Prostate cancer is one of the cancers included in the 100,000 Genomes project. Researchers analyse the genetic information through the Genomics England Clinical Interpretation Partnership.

The 100,000 Genomes Project has to date completed 5,356 whole genome sequences of cancer samples, including prostate cancer.

This is leading to the development of new and more personalised diagnostic pathways that will support future research, clinical trials and diagnostic treatment pathways and medicines.

Research results will inform the development of a National Health Service-wide Genomic Medicine Service that maximises the opportunity for research insights to improve outcome of patients, among others, cancer patients including prostate cancer sufferers.